(Q43038126)

12 November 2017

title

Automated screening of blood donations for hepatitis C virus RNA using the Qiagen BioRobot 9604 and the Roche COBAS HCV Amplicor assay (English)

1 reference

12 November 2017

1 reference

1 reference

Grant PR

1

1 reference

12 November 2017

Sims CM

2

1 reference

12 November 2017

Krieg-Schneider F

3

1 reference

12 November 2017

Love EM

4

1 reference

12 November 2017

Eglin R

5

1 reference

12 November 2017

Tedder RS

6

1 reference

12 November 2017

publication date

1 May 2002

1 reference

12 November 2017

1 reference

12 November 2017

volume

82

1 reference

12 November 2017

issue

4

1 reference

12 November 2017

page(s)

169-176

1 reference

The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1423-0410.2002.00177.X

Improved detection of anti-HCV in post-transfusion hepatitis by a third-generation ELISA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1423-0410.2002.00177.X

The risks of infection transmission by blood transfusion in England

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1423-0410.2002.00177.X

Serious hazards of transfusion (SHOT) initiative: analysis of the first two annual reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1423-0410.2002.00177.X

Effects of handling and storage of blood on the stability of hepatitis C virus RNA: implications for NAT testing in transfusion practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1423-0410.2002.00177.X

Calibration of HCV working reagents for NAT assays against the HCV international standard. The Collaborative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1423-0410.2002.00177.X

Validation of the NucliSens Extractor in combination with the hepatitis C virus Cobas Amplicor 2.0 assay in four laboratories in the Netherlands utilizing nucleic acid amplification technology for blood screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1423-0410.2002.00177.X

Experiences in HCV-NAT screening prior to releasing cellular components by the German Red Cross Blood Transfusion Service of Baden-Württemberg

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1423-0410.2002.00177.X

Screening blood donations for hepatitis C virus by polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1423-0410.2002.00177.X

Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1423-0410.2002.00177.X

NAT of the United States and Canadian blood supply

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1423-0410.2002.00177.X

10.1046/J.1423-0410.2002.00177.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference